Stock Price Quote

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE75.260.57 (+0.76 %)
PREV CLOSE ( ) 74.69
OPEN PRICE ( ) 74.00
BID PRICE (QTY) 75.04 (72)
OFFER PRICE (QTY) 75.41 (401)
VOLUME 31
TODAY'S LOW / HIGH ( )74.00 75.26
52 WK LOW / HIGH ( )73.56 167.1
NSE75.320.86 (+1.15 %)
PREV CLOSE( ) 74.46
OPEN PRICE ( ) 75.43
BID PRICE (QTY) 75.32 (31)
OFFER PRICE (QTY) 75.33 (29)
VOLUME 3493
TODAY'S LOW / HIGH( ) 74.75 75.88
52 WK LOW / HIGH ( )72.2 167.19
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-12 1976
Management Info
Babulal Jain - Chairman Kunal N Gandhi - Managing Director
Registered Office

Address 4801/B & 4802/A,G I D C Industrial Estate, ,
Ankleshwar,
Gujarat-393002

Phone 02646-221422 /220549

Email companysecretary@lykalabs.com

Website www.lykalabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

23Oct Lyka Labs submits board meeting intima
Lyka Labs has informed that a meeting of the Board of Directors of the C..
11Oct Lyka Labs informs about compliance cer
In compliance with Regulation 74 (5) of the SEBI (Depositories and Parti..
24Sep Appointment of Director
Inter-alia, to consider and transact following major businesses: 1. To..
05Sep Lyka Labs informs about GST Audit
Lyka Labs has informed that the company has received GST Audit Observati..
21Jul Lyka Labs informs about board meeting
Lyka Labs has informed that a meeting of the Board of Directors of the C..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit-36.2882.2799999999999
Gross Profit -47.98 114.75
Operating Profit -19.41202.32
Net Sales 329.71346.97

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE)
peergroup  1787.75 (2.54%)
M.Cap ( in Cr)849.90
RPG Life Sciences (BSE)
peergroup  2339.90 (1.44%)
M.Cap ( in Cr)3837.05
Onesource Specialty (BSE)
peergroup  1616.70 (1.59%)
M.Cap ( in Cr)18362.84
Lupin (BSE)
peergroup  2114.40 (1.18%)
M.Cap ( in Cr)96747.70
Pfizer (BSE)
peergroup  5040.65 (0.45%)
M.Cap ( in Cr)23055.26

Shareholding Pattern

PROMOTERS 58.16%
NON-INSTITUTION 41%
FI/BANKS/INSURANCE 0.28%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Lyka Labs Ltd.

Lyka Labs Ltd. was incorporated in the year 1976. Its today's share price is 75.26. Its current market capitalisation stands at Rs 268.6 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1346.97 Cr and Total Income of Rs.1370.41 Cr. The company's management includes Shailendra Kumar Agrawal, Kunal N Gandhi, Shashil P Mendonsa, Prashant Godha, Archana Yadav, Neeraj Golas, Yogesh Shah, Babulal Jain.

It is listed on the BSE with a BSE Code of 500259 , NSE with an NSE Symbol of LYKALABS and ISIN of INE933A01014. It's Registered office is at 4801/B & 4802/A,G I D C Industrial Estate, Ankleshwar-393002, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are D Kothary & Co, MA Parikh & Co, Mehta Chokshi & Shah

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.